SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Jun 11, 2007	View HTML 0001144204-07-031298.pdf 0001144204-07-031298.rtf 0001144204-07-031298.xls
424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Mar 17, 2014	View HTML 0001193125-14-102176.pdf 0001193125-14-102176.rtf 0001193125-14-102176.xls
4/A	Amendment to a previously filed 4	Oct 09, 2012	View HTML 0000904454-12-000538.pdf 0000904454-12-000538.rtf
4/A	Amendment to a previously filed 4	Jun 22, 2018	View HTML 0000899243-18-017684.pdf 0000899243-18-017684.rtf
4/A	Amendment to a previously filed 4	Sep 09, 2022	View HTML 0001562180-22-006580.pdf 0001562180-22-006580.rtf 0001562180-22-006580.xls
4/A	Amendment to a previously filed 4	Aug 30, 2023	View HTML 0000899243-23-018606.pdf 0000899243-23-018606.rtf 0000899243-23-018606.xls
4/A	Amendment to a previously filed 4	Sep 06, 2023	View HTML 0000899243-23-018661.pdf 0000899243-23-018661.rtf 0000899243-23-018661.xls
4/A	Amendment to a previously filed 4	Dec 11, 2023	View HTML 0001562180-23-008273.pdf 0001562180-23-008273.rtf 0001562180-23-008273.xls
4/A	Amendment to a previously filed 4	Jan 03, 2024	View HTML 0001562180-24-000133.pdf 0001562180-24-000133.rtf 0001562180-24-000133.xls
4	Statement of changes in beneficial ownership of securities	Nov 20, 2009	View HTML 0001181431-09-053098.pdf 0001181431-09-053098.rtf

Data provided by Kaleidoscope.